{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:05:01Z","timestamp":1791389101812,"version":"4.3.3"},"reference-count":50,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2024.0255","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T14:43:03Z","timestamp":1739889783000},"source":"Crossref","is-referenced-by-count":7,"title":["Acute on chronic liver failure"],"prefix":"10.3238","author":[{"given":"Jonel","family":"Trebicka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Praktiknjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Henrik","family":"Peiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Pascher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin Sebastian","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank Erhard","family":"Uschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"key":"10.3238\/arztebl.m2024.0255_ref1","unstructured":"Sauerbruch T, Strassburg CP, Trebicka J (eds.): Therapie-Handbuch \u2013 Gastroenterologie und Hepatologie. M\u00fcnchen: Elsevier GmbH 2024."},{"key":"10.3238\/arztebl.m2024.0255_ref2","doi-asserted-by":"crossref","unstructured":"D\u2019Amico G, Pasta L, Morabito A, et al.: Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients. Aliment Pharmacol Ther 2014; 39: 1180\u201393.","DOI":"10.1111\/apt.12721"},{"key":"10.3238\/arztebl.m2024.0255_ref3","doi-asserted-by":"crossref","unstructured":"Schulz MS, Angeli P, Trebicka J: Acute and non-acute decompensation of liver cirrhosis (47\/130). Liver Int 2024; doi: 10.1111\/liv.15861. Online ahead of print.","DOI":"10.1111\/liv.15861"},{"key":"10.3238\/arztebl.m2024.0255_ref4","doi-asserted-by":"crossref","unstructured":"Gu W, Hortlik H, Erasmus HP, et al.: Trends and the course of liver cirrhosis and its complications in Germany: Nationwide population-based study (2005 to 2018). Lancet Reg Health Eur 2021; 12: 100240.","DOI":"10.1016\/j.lanepe.2021.100240"},{"key":"10.3238\/arztebl.m2024.0255_ref5","doi-asserted-by":"crossref","unstructured":"Mokdad AA, Lopez AD, Shahraz S, et al.: Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med 2014; 12: 145.","DOI":"10.1186\/s12916-014-0145-y"},{"key":"10.3238\/arztebl.m2024.0255_ref6","doi-asserted-by":"crossref","unstructured":"Mezzano G, Juanola A, Cardenas A, et al.: Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis. Gut 2022; 71: 148\u201355.","DOI":"10.1136\/gutjnl-2020-322161"},{"key":"10.3238\/arztebl.m2024.0255_ref7","doi-asserted-by":"crossref","unstructured":"Moreau R, Jalan R, Gines P, et al.: Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013; 144: 1426\u201337, 1437.e1\u20139.","DOI":"10.1053\/j.gastro.2013.02.042"},{"key":"10.3238\/arztebl.m2024.0255_ref8","doi-asserted-by":"crossref","unstructured":"Devani K, Charilaou P, Jaiswal P, et al.: Trends in hospitalization, acute kidney injury, and mortality in patients with spontaneous bacterial peritonitis. J Clin Gastroenterol 2019; 53: e68\u2013e74.","DOI":"10.1097\/MCG.0000000000000973"},{"key":"10.3238\/arztebl.m2024.0255_ref9","doi-asserted-by":"crossref","unstructured":"Nadim MK, Kellum JA, Forni L, et al.: Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting. J Hepatol 2024; 81: 163\u201383.","DOI":"10.1016\/j.jhep.2024.03.031"},{"key":"10.3238\/arztebl.m2024.0255_ref10","doi-asserted-by":"crossref","unstructured":"Trebicka J, Fernandez J, Papp M, et al.: The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology. J Hepatol 2020; 73: 842\u201354.","DOI":"10.1016\/j.jhep.2020.06.013"},{"key":"10.3238\/arztebl.m2024.0255_ref11","doi-asserted-by":"crossref","unstructured":"Rueschenbaum S, Ciesek S, Queck A, et al.: Dysregulated adaptive immunity is an early event in liver cirrhosis preceding acute-on-chronic liver failure. Front Immunol 2021: 11: 534731.","DOI":"10.3389\/fimmu.2020.534731"},{"key":"10.3238\/arztebl.m2024.0255_ref12","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez-Gea V, Aracil C, Colomo A, et al.: Development of ascites in compensated cirrhosis with severe portal hypertension treated with β-blockers. Am J Gastroenterol 2012; 107: 418\u201327.","DOI":"10.1038\/ajg.2011.456"},{"key":"10.3238\/arztebl.m2024.0255_ref13","doi-asserted-by":"crossref","unstructured":"de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C, Baveno VII Faculty: Baveno VII\u2014renewing consensus in portal hypertension. J Hepatol 2022; 76: 959\u201374.","DOI":"10.1007\/978-3-031-08552-9"},{"key":"10.3238\/arztebl.m2024.0255_ref14","doi-asserted-by":"crossref","unstructured":"Trebicka J, Amoros A, Pitarch C, et al.: Addressing profiles of systemic inflammation across the different clinical phenotypes of acutely decompensated cirrhosis. Front Immunol 2019; 10: 476.","DOI":"10.3389\/fimmu.2019.00476"},{"key":"10.3238\/arztebl.m2024.0255_ref15","doi-asserted-by":"crossref","unstructured":"Arroyo V, Moreau R, Jalan R: Acute-on-chronic liver failure. N Engl J Med 2020; 382: 2137\u201345.","DOI":"10.1056\/NEJMra1914900"},{"key":"10.3238\/arztebl.m2024.0255_ref16","doi-asserted-by":"crossref","unstructured":"Villanueva C, Albillos A, Genesc\u00e0 J, et al.: β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet 2019; 393: 1597\u2013608.","DOI":"10.1016\/S0140-6736(18)31875-0"},{"key":"10.3238\/arztebl.m2024.0255_ref17","doi-asserted-by":"crossref","unstructured":"Trebicka J: Does transjugular intrahepatic portosystemic shunt stent differentially improve survival in a subset of cirrhotic patients? Semin Liver Dis 2018; 38: 87\u201396.","DOI":"10.1055\/s-0038-1627457"},{"key":"10.3238\/arztebl.m2024.0255_ref18","doi-asserted-by":"crossref","unstructured":"Praktiknjo M, Abu-Omar J, Chang J, et al.: Controlled underdilation using novel VIATORR\u00ae controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation. JHEP Rep 2021; 3: 100264.","DOI":"10.1016\/j.jhepr.2021.100264"},{"key":"10.3238\/arztebl.m2024.0255_ref19","doi-asserted-by":"crossref","unstructured":"Caraceni P, Riggio O, Angeli P, et al.: Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial. Lancet 2018; 391: 2417\u201329.","DOI":"10.1016\/S0140-6736(18)30840-7"},{"key":"10.3238\/arztebl.m2024.0255_ref20","doi-asserted-by":"crossref","unstructured":"Torp N, Israelsen M, Coenraad M, et al.: Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL\u2014a randomised clinical biomarker validation trial. BMJ Open 2024; 14: e079309.","DOI":"10.1136\/bmjopen-2023-079309"},{"key":"10.3238\/arztebl.m2024.0255_ref21","doi-asserted-by":"crossref","unstructured":"Trebicka J, Fernandez J, Papp M, et al.: PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis. J Hepatol 2021; 74: 1097\u2013108.","DOI":"10.1016\/j.jhep.2020.11.012"},{"key":"10.3238\/arztebl.m2024.0255_ref22","doi-asserted-by":"crossref","unstructured":"Crabb DW, Bataller R, Chalasani NP, et al.: Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA alcoholic hepatitis consortia. Gastroenterology 2016; 150: 785\u201390.","DOI":"10.1053\/j.gastro.2016.02.042"},{"key":"10.3238\/arztebl.m2024.0255_ref23","doi-asserted-by":"crossref","unstructured":"Arabi YM, Dara SI, Memish Z, et al.: Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis. Hepatology 2012; 56: 2305\u201315.","DOI":"10.1002\/hep.25931"},{"key":"10.3238\/arztebl.m2024.0255_ref24","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver: EASL clinical practice guidelines on acute-on-chronic liver failure. J Hepatol 2023; 79: 461\u201391.","DOI":"10.1016\/j.jhep.2023.04.021"},{"key":"10.3238\/arztebl.m2024.0255_ref25","doi-asserted-by":"crossref","unstructured":"Gerbes AL, Labenz J, Appenrodt B, et al.: Aktualisierte S2k-Leitlinie der Deutschen Gesellschaft f\u00fcr Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) \u201eKomplikationen der Leberzirrhose\u201c: AWMF-Nr.: 021\u2013017. Z Gastroenterol 2019; 57: 611\u201380.","DOI":"10.1055\/a-0873-4658"},{"key":"10.3238\/arztebl.m2024.0255_ref26","doi-asserted-by":"crossref","unstructured":"Wong F, Piano S, Singh V, et al.: Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure. J Hepatol 2021; 74: 330\u20139.","DOI":"10.1016\/j.jhep.2020.07.046"},{"key":"10.3238\/arztebl.m2024.0255_ref27","doi-asserted-by":"crossref","unstructured":"Gawrieh S, Dasarathy S, Tu W, et al.: Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis. J Hepatol 2024; 80: 684\u201393.","DOI":"10.1016\/j.jhep.2024.01.031"},{"key":"10.3238\/arztebl.m2024.0255_ref28","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver: EASL clinical practice guidelines: management of alcohol-related liver disease. J Hepatol 2018; 69: 154\u201381.","DOI":"10.1016\/j.jhep.2018.03.018"},{"key":"10.3238\/arztebl.m2024.0255_ref29","doi-asserted-by":"crossref","unstructured":"Trebicka J, Gu W, Ib\u00e1\u00f1ez-Samaniego L, et al.: Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS. J Hepatol 2020; 73: 1082\u201391.","DOI":"10.1016\/j.jhep.2020.04.024"},{"key":"10.3238\/arztebl.m2024.0255_ref30","doi-asserted-by":"crossref","unstructured":"Wong F, Pappas SC, Curry MP, et al.: Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome. N Engl J Med 2021; 384: 818\u201328.","DOI":"10.1056\/NEJMoa2008290"},{"key":"10.3238\/arztebl.m2024.0255_ref31","doi-asserted-by":"crossref","unstructured":"M\u00fccke MM, Hern\u00e1ndez-Tejero M, Gu W, et al.: Terlipressin therapy is associated with increased risk of colonisation with multidrug-resistant bacteria in patients with decompensated cirrhosis. Aliment Pharmacol Ther 2024; 59: 877\u201388.","DOI":"10.1111\/apt.17899"},{"key":"10.3238\/arztebl.m2024.0255_ref32","doi-asserted-by":"crossref","unstructured":"Saner FH, Bezinover D: Assessment and management of coagulopathy in critically-ill patients with liver failure. Curr Opin Crit Care 2019; 25: 179\u201386.","DOI":"10.1097\/MCC.0000000000000591"},{"key":"10.3238\/arztebl.m2024.0255_ref33","doi-asserted-by":"crossref","unstructured":"Bernal W, Karvellas C, Saliba F, Saner FH, Meersseman P: Intensive care management of acute-on-chronic liver failure. J Hepatol 2021; 75 (Suppl 1): S163\u201377.","DOI":"10.1016\/j.jhep.2020.10.024"},{"key":"10.3238\/arztebl.m2024.0255_ref34","doi-asserted-by":"crossref","unstructured":"Ba\u00f1ares R, Ib\u00e1\u00f1ez-Samaniego L, Torner JM, et al.: Meta-analysis of individual patient data of albumin dialysis in acute-on-chronic liver failure: focus on treatment intensity. Therap Adv Gastroenterol 2019; 12: 1756284819879565.","DOI":"10.1177\/1756284819879565"},{"key":"10.3238\/arztebl.m2024.0255_ref35","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez J, Lozano M, Torres M, et al.: Effect of plasma exchange with albumin replacement on albumin functionality and organ dysfunction in acute-on-chronic liver failure. JHEP Rep 2024; 6: 101017.","DOI":"10.1016\/j.jhepr.2024.101017"},{"key":"10.3238\/arztebl.m2024.0255_ref36","doi-asserted-by":"crossref","unstructured":"Gustot T, Fernandez J, Garcia E, et al.: Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis. Hepatology 2015; 62: 243\u201352.","DOI":"10.1002\/hep.27849"},{"key":"10.3238\/arztebl.m2024.0255_ref37","doi-asserted-by":"crossref","unstructured":"Belli LS, Duvoux C, Artzner T, et al.: Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: results of the ELITA\/EF-CLIF collaborative study (ECLIS). J Hepatol 2021; 75: 610\u201322.","DOI":"10.1016\/j.jhep.2021.03.030"},{"key":"10.3238\/arztebl.m2024.0255_ref38","doi-asserted-by":"crossref","unstructured":"Trebicka J, Sundaram V, Moreau R, Jalan R, Arroyo V: Liver transplantation for acute-on-chronic liver failure: science or fiction? Liver Transpl 2020; 26: 906\u201315.","DOI":"10.1002\/lt.25788"},{"key":"10.3238\/arztebl.m2024.0255_ref39","doi-asserted-by":"crossref","unstructured":"Jalan R, D\u2019Amico G, Trebicka J, Moreau R, Angeli P, Arroyo V: New clinical and pathophysiological perspectives defining the trajectory of cirrhosis. J Hepatol 2021; 75 (Suppl 1): S14\u201326.","DOI":"10.1016\/j.jhep.2021.01.018"},{"key":"10.3238\/arztebl.m2024.0255_ref40","doi-asserted-by":"crossref","unstructured":"Praktiknjo M, Sim\u00f3n-Talero M, R\u00f6mer J, et al.: Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis. J Hepatol 2020; 72: 1140\u201350.","DOI":"10.1016\/j.jhep.2019.12.021"},{"key":"10.3238\/arztebl.m2024.0255_ref41","doi-asserted-by":"crossref","unstructured":"Laleman W, Simon-Talero M, Maleux G, et al.: Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: a multicenter survey on safety and efficacy. Hepatology 2013; 57: 2448\u201357.","DOI":"10.1002\/hep.26314"},{"key":"10.3238\/arztebl.m2024.0255_ref42","doi-asserted-by":"crossref","unstructured":"Cl\u00e0ria J, Stauber RE, Coenraad MJ, et al.: Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure. Hepatology 2016; 64: 1249\u201364.","DOI":"10.1002\/hep.28740"},{"key":"10.3238\/arztebl.m2024.0255_ref43","doi-asserted-by":"crossref","unstructured":"Arroyo V, Angeli P, Moreau R, et al.: The systemic inflammation hypothesis: towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis. J Hepatol 2021; 74: 670\u201385.","DOI":"10.1016\/j.jhep.2020.11.048"},{"key":"10.3238\/arztebl.m2024.0255_ref44","doi-asserted-by":"crossref","unstructured":"Chang J, Bamarni A, B\u00f6hling N, et al.: Elective surgery but not transjugular intrahepatic portosystemic shunt precipitates acute-on-chronic liver failure. Hepatol Commun 2021; 5: 1265\u201377.","DOI":"10.1002\/hep4.1712"},{"key":"10.3238\/arztebl.m2024.0255_ref45","doi-asserted-by":"crossref","unstructured":"Chang J, H\u00f6fer P, B\u00f6hling N, et al.: Preoperative TIPS prevents the development of postoperative acute-on-chronic liver failure in patients with high CLIF-C AD score. JHEP Rep 2022; 4: 100442.","DOI":"10.1016\/j.jhepr.2022.100442"},{"key":"10.3238\/arztebl.m2024.0255_ref46","doi-asserted-by":"crossref","unstructured":"Bhardwaj A, Kedarisetty CK, Vashishtha C, et al.: Carvedilol delays the progression of small oesophageal varices in patients with cirrhosis: a randomised placebo-controlled trial. Gut 2017; 66: 1838\u201343.","DOI":"10.1136\/gutjnl-2016-311735"},{"key":"10.3238\/arztebl.m2024.0255_ref47","doi-asserted-by":"crossref","unstructured":"Lv Y, Yang Z, Liu L, et al.: Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial. Lancet Gastroenterol Hepatol 2019; 4: 587\u201398.","DOI":"10.1016\/S2468-1253(19)30090-1"},{"key":"10.3238\/arztebl.m2024.0255_ref48","doi-asserted-by":"crossref","unstructured":"Bureau C, Thabut D, Oberti F, et al.: Transjugular intrahepatic portosystemic shunts with covered stents increase transplant-free survival of patients with cirrhosis and recurrent ascites. Gastroenterology 2017; 152: 157\u201363.","DOI":"10.1053\/j.gastro.2016.09.016"},{"key":"10.3238\/arztebl.m2024.0255_ref49","doi-asserted-by":"crossref","unstructured":"Sanyal AJ, Kowdley KV, Reau NS, et al.: Rifaximin plus lactulose versus lactulose alone for reducing the risk of HE recurrence. Hepatol Commun 2024; 8: e0436.","DOI":"10.1097\/HC9.0000000000000436"},{"key":"10.3238\/arztebl.m2024.0255_ref50","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez J, Navasa M, Planas R, et al.: Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology 2007; 133: 818\u201324.","DOI":"10.1053\/j.gastro.2007.06.065"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2024.0255","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T14:43:50Z","timestamp":1739889830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2024.0255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":50,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2024.0255","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,21]]}}}